Dyne Therapeutics, Inc. DYN Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $398.33M+41.6% | $281.41M+33.5% | $210.76M+47.6% | $142.76M+17.7% | ||
| $69.85M+11.8% | $62.48M+99.0% | $31.4M+11.3% | $28.2M-1.8% | ||
| $468.18M+36.1% | $343.89M+42.0% | $242.16M+41.6% | $170.96M+14.0% | ||
| -$468.18M-36.2% | -$343.8M-42.0% | -$242.16M-41.6% | -$170.96M-14.0% | ||
| $6.19M— | $0— | $0— | —— | ||
| $21.97M-17.0% | $26.47M+325% | $6.22M+117% | $2.86M+290% | ||
| -$446.21M-40.6% | -$317.42M-34.5% | -$235.94M-40.4% | -$168.1M-12.6% | ||
| -$3.51-4.8% | -$3.35+15.0% | -$3.94-22.0% | -$3.23-10.6% | ||
| -$466.16M-36.2% | -$342.16M-42.2% | -$240.55M-42.1% | -$169.24M-13.6% | ||
| -$468.18M-36.2% | -$343.8M-42.0% | -$242.16M-41.6% | -$170.96M-14.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dyne Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Dyne Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.